文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

院内外膜肺氧合心肺复苏治疗院外心脏骤停患者:基于日本全国数据库的时间依赖倾向评分匹配分析

In-hospital extracorporeal cardiopulmonary resuscitation for patients with out-of-hospital cardiac arrest: an analysis by time-dependent propensity score matching using a nationwide database in Japan.
PubMed 文献 · Crit Care · 2023-11-15
一句话结论日本全国登记数据显示,ECPR与院外心脏骤停患者30天生存率提高相关(可电击心律OR 1.76,不可电击心律OR 5.37),但可电击心律的神经功能预后无显著改善。

本研究为JAAM-OHCA登记数据库的二次分析,纳入2014年6月至2019年12月日本全国多中心前瞻性研究中≥18岁的院外心脏骤停成人患者。按初始心律分为可电击与不可电击两组,采用时间依赖倾向评分进行风险集匹配,ECPR组与非ECPR对照组在同一时间窗内序贯配对。匹配后可电击心律组1826例(ECPR 913例 vs 对照913例),不可电击心律组740例(ECPR 370例 vs 对照370例)。ECPR组30天生存OR在可电击心律为1.76(95%CI 1.38-2.25)、不可电击心律为5.37(95%CI 2.53-11.43);神经功能良好结局OR在可电击心律为1.11(95%CI 0.82-1.49)、不可电击心律为4.25(95%CI 1.43-12.63)。作者认为需进一步研究结果的重复性及ECPR最佳候选人群。

要点

  • 可电击心律院外心脏骤停:ECPR组30天生存OR 1.76(95%CI 1.38-2.25),神经功能良好结局OR 1.11(95%CI 0.82-1.49),后者未达统计学显著。
  • 不可电击心律院外心脏骤停:ECPR组30天生存OR 5.37(95%CI 2.53-11.43),神经功能良好结局OR 4.25(95%CI 1.43-12.63)。
  • 匹配队列来自日本全国多中心前瞻性JAAM-OHCA登记,可电击心律ECPR 913例 vs 对照913例,不可电击心律ECPR 370例 vs 对照370例。
  • 作者结论:ECPR与可电击及不可电击心律院外心脏骤停患者30天生存率提高相关,需进一步研究结果重复性及最佳候选人群。

适用人群与场景

  • JAAM-OHCA登记中≥18岁的院外心脏骤停成人患者,初始心律分为可电击心律与不可电击心律。

研究设计与关键结果

  • 研究类型:JAAM-OHCA全国多中心前瞻性登记数据的二次分析,采用时间依赖倾向评分风险集匹配,匹配时间窗为同一时间(分钟)。
  • 可电击心律匹配队列1826例(ECPR 913例 vs 对照913例):30天生存OR 1.76(95%CI 1.38-2.25);神经功能良好结局OR 1.11(95%CI 0.82-1.49)。
  • 不可电击心律匹配队列740例(ECPR 370例 vs 对照370例):30天生存OR 5.37(95%CI 2.53-11.43);神经功能良好结局OR 4.25(95%CI 1.43-12.63)。

证据类型、等级与局限

  • 证据类型:全国多中心前瞻性登记数据的二次分析(观察性研究)。
  • 局限:作者指出需进一步研究以验证结果的重复性并明确ECPR的最佳候选人群。

对床旁实践的改变

  • 作者认为ECPR与可电击及不可电击心律院外心脏骤停患者30天生存率提高相关,但可电击心律的神经功能良好结局未达统计学显著(OR 1.11,95%CI 0.82-1.49)。
  • 作者建议进一步研究结果的重复性及ECPR最佳候选人群。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Extracorporeal cardiopulmonary resuscitation (ECPR) has been proposed as a rescue therapy for patients with refractory cardiac arrest. This study aimed to evaluate the association between ECPR and clinical outcomes among patients with out-of-hospital cardiac arrest (OHCA) using risk-set matching with a time-dependent propensity score.

METHODS: This was a secondary analysis of the JAAM-OHCA registry data, a nationwide multicenter prospective study of patients with OHCA, from June 2014 and December 2019, that included adults (≥ 18 years) with OHCA. Initial cardiac rhythm was classified as shockable and non-shockable. Patients who received ECPR were sequentially matched with the control, within the same time (minutes) based on time-dependent propensity scores calculated from potential confounders. The odds ratios with 95% confidence intervals (CI) for 30-day survival and 30-day favorable neurological outcomes were estimated for ECPR cases using a conditional logistic model.

RESULTS: Of 57,754 patients in the JAAM-OHCA registry, we selected 1826 patients with an initial shockable rhythm (treated with ECPR, n = 913 and control, n = 913) and a cohort of 740 patients with an initial non-shockable rhythm (treated with ECPR, n = 370 and control, n = 370). In these matched cohorts, the odds ratio for 30-day survival in the ECPR group was 1.76 [95%CI 1.38-2.25] for shockable rhythm and 5.37 [95%CI 2.53-11.43] for non-shockable rhythm, compared to controls. For favorable neurological outcomes, the odds ratio in the ECPR group was 1.11 [95%CI 0.82-1.49] for shockable rhythm and 4.25 [95%CI 1.43-12.63] for non-shockable rhythm, compared to controls.

CONCLUSION: ECPR was associated with increased 30-day survival in patients with OHCA with initial shockable and even non-shockable rhythms. Further research is warranted to investigate the reproducibility of the results and who is the best candidate for ECPR.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Okada Y, Komukai S, Irisawa T, et al. In-hospital extracorporeal cardiopulmonary resuscitation for patients with out-of-hospital cardiac arrest: an analysis by time-dependent propensity score matching using a nationwide database in Japan. Crit Care. 2023. PMID: 37968720. doi:10.1186/s13054-023-04732-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。